Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
746.60
-3.10 (-0.41%)
At close: Mar 4, 2026
Ambee Pharmaceuticals Market Cap
Ambee Pharmaceuticals has a market cap or net worth of 1.79 billion as of March 4, 2026. Its market cap has decreased by -1.33% in one year.
Market Cap
1.79B
Enterprise Value
2.34B
Revenue
193.90M
Ranking
n/a
PE Ratio
371.72
Stock Price
746.60
Market Cap Chart
Since March 3, 2008, Ambee Pharmaceuticals's market cap has increased from 123.20M to 1.79B, an increase of 1,354.42%. That is a compound annual growth rate of 16.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.80B | 5.89% |
| Dec 30, 2025 | 1.70B | 0.87% |
| Dec 30, 2024 | 1.68B | -13.94% |
| Dec 28, 2023 | 1.96B | 58.77% |
| Dec 29, 2022 | 1.23B | 11.94% |
| Dec 30, 2021 | 1.10B | 2.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orion Pharma | 7.39B |
| Asiatic Laboratories | 7.23B |
| Navana Pharmaceuticals | 6.73B |
| Techno Drugs | 4.20B |
| Pharma Aids | 1.72B |
| Indo-Bangla Pharmaceuticals | 1.64B |
| Silco Pharmaceuticals | 1.54B |
| Libra Infusions | 1.52B |